Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Covalon Technologies Ltd.
Nieuws
Covalon Technologies Ltd.
COV
TVX
: COV
| ISIN: CA22282D3022
16/05/2024
1,090 CAD
(-1,80%)
(-1,80%)
16/05/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Technische analyse
TA
Toon enkel gratis nieuws
26 april 2023 ·
Compassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Access Joint Conference on April 26-28, 2023 in Toronto
· Persbericht
27 maart 2023 ·
Covalon Presents New CLABSI Conscious Series Webinar: Protecting CVADs from Gross Contamination
· Persbericht
20 maart 2023 ·
Leader in Compassionate Care Infection Prevention Solutions, Covalon, to Participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023
· Persbericht
9 maart 2023 ·
Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders
· Persbericht
9 maart 2023 ·
Covalon Welcomes Martin Goldfarb, O.C., to its Board of Directors
· Persbericht
28 februari 2023 ·
Covalon To Hold Annual and Special Meeting of Shareholders on Wednesday, March 8, 2023
· Persbericht
23 februari 2023 ·
Covalon Announces Improved First Quarter Fiscal 2023 Results
· Persbericht
20 februari 2023 ·
Infection Prevention Solutions Provider Covalon to Participate for the First Time in NEO - The Conference for Neonatology in Las Vegas, NV on February 22-24, 2023
· Persbericht
18 februari 2023 ·
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2023 Financial Results
· Persbericht
26 januari 2023 ·
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2022 and Highlights Company Transformation Changes
· Persbericht
23 januari 2023 ·
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2022 Financial Results
· Persbericht
21 november 2022 ·
Covalon's SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children's Hospital
· Persbericht
8 november 2022 ·
Covalon Launches New "CLABSI Conscious" Campaign to Help Children Heal Without Infections
· Persbericht
1 november 2022 ·
Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds
· Persbericht
11 oktober 2022 ·
Covalon to Participate in the American Nurses Credentialing Center Magnet Conference in Philadelphia
· Persbericht
28 september 2022 ·
Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto
· Persbericht
26 september 2022 ·
Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting
· Persbericht
20 september 2022 ·
Covalon's Dual Antimicrobial Surgical Site Dressing Adopted by Leading US Pediatric Hospital's Congenital Heart Program
· Persbericht
13 september 2022 ·
Covalon to Introduce New Infection Prevention Products at the Annual Association of Pediatric Hematology/Oncology Nurses (APHON) Conference
· Persbericht
8 september 2022 ·
Covalon Announces Expansion of its United States Pediatric Hospital Customer Base
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe